XML 35 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidating Financial Statements (Tables)
3 Months Ended 9 Months Ended
Dec. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]      
Condensed Consolidating Balance Sheet  
Condensed Consolidating Balance Sheet (1)
March 31, 2014
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
ASSETS
 

 
 

 
 

 
 

 
 

Current assets:
 

 
 

 
 

 
 

 
 

Cash and cash equivalents
$
616

 
$
22,200

 
$
35,113

 
$

 
$
57,929

Accounts receivable, net

 
49,462

 
49,485

 

 
98,947

Intercompany receivable
318,582

 
329,211

 
203,018

 
(850,811
)
 

Inventories, net

 
119,340

 
68,634

 

 
187,974

Prepaid expenses and other
3,146

 
15,286

 
21,380

 
(2,941
)
 
36,871

Deferred income taxes

 
1,022

 
5,673

 

 
6,695

Current assets of discontinued operations

 

 
12,160

 

 
12,160

Total current assets
322,344

 
536,521

 
395,463

 
(853,752
)
 
400,576

Property and equipment, net
329

 
104,874

 
187,445

 

 
292,648

Goodwill

 
35,584

 

 

 
35,584

Intangible assets, net

 
28,380

 
8,804

 

 
37,184

Investment in NEC TOKIN

 
46,419

 

 

 
46,419

Investments in subsidiaries
402,090

 
424,386

 
30,285

 
(856,761
)
 

Restricted cash

 
13,512

 

 

 
13,512

Deferred income taxes

 
1,010

 
5,768

 

 
6,778

Other assets
5,415

 
3,895

 
820

 

 
10,130

Non-current assets of discontinued operations

 

 
836

 

 
836

Long-term intercompany receivable
81,746

 
60,663

 
2,801

 
(145,210
)
 

Total assets
$
811,924

 
$
1,255,244

 
$
632,222

 
$
(1,855,723
)
 
$
843,667

LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

 
 

 
 

 
 

Current liabilities:
 

 
 

 
 

 
 

 
 

Current portion of long-term debt
$
5,988

 
$

 
$
1,309

 
$

 
$
7,297

Accounts payable
84

 
36,579

 
38,155

 

 
74,818

Intercompany payable
176,624

 
570,535

 
103,652

 
(850,811
)
 

Accrued expenses
34,236

 
13,698

 
28,534

 

 
76,468

Income taxes payable and deferred income taxes

 
2,909

 
1,012

 
(2,941
)
 
980

Current liabilities of discontinued operations

 

 
7,269

 

 
7,269

Total current liabilities
216,932

 
623,721

 
179,931

 
(853,752
)
 
166,832

Long-term debt, less current portion
372,251

 
6,449

 
12,592

 

 
391,292

Other non-current obligations
857

 
3,311

 
51,696

 

 
55,864

Deferred income taxes

 
3,258

 
1,945

 

 
5,203

Non-current liabilities of discontinued operations

 

 
2,592

 

 
2,592

Long-term intercompany payable

 
81,747

 
63,463

 
(145,210
)
 

Stockholders’ equity
221,884

 
536,758

 
320,003

 
(856,761
)
 
221,884

Total liabilities and stockholders’ equity
$
811,924

 
$
1,255,244

 
$
632,222

 
$
(1,855,723
)
 
$
843,667


(1) Derived from audited financial statements.
Condensed Consolidating Balance Sheet
December 31, 2014
(Unaudited)

 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
ASSETS
 

 
 

 
 

 
 

 
 

Current assets:
 

 
 

 
 

 
 

 
 

Cash and cash equivalents
$
640

 
$
29,936

 
$
25,006

 
$

 
$
55,582

Accounts receivable, net

 
38,148

 
54,337

 

 
92,485

Intercompany receivable
320,682

 
413,279

 
202,659

 
(936,620
)
 

Inventories, net

 
127,906

 
59,708

 

 
187,614

Prepaid expenses and other
3,146

 
15,684

 
22,947

 
(2,941
)
 
38,836

Deferred income taxes

 
2,314

 
4,381

 

 
6,695

Total current assets
324,468

 
627,267

 
369,038

 
(939,561
)
 
381,212

Property and equipment, net
305

 
100,025

 
164,638

 

 
264,968

Goodwill

 
35,584

 

 

 
35,584

Intangible assets, net

 
27,343

 
7,252

 

 
34,595

Investment in NEC TOKIN

 
52,168

 

 

 
52,168

Investments in subsidiaries
434,413

 
423,462

 
31,135

 
(889,010
)
 

Restricted cash

 
2,003

 

 

 
2,003

Deferred income taxes

 
948

 
5,743

 

 
6,691

Other assets
4,419

 
17,167

 
937

 

 
22,523

Long-term intercompany receivable
71,982

 
56,574

 
2,800

 
(131,356
)
 

Total assets
$
835,587

 
$
1,342,541

 
$
581,543

 
$
(1,959,927
)
 
$
799,744

LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

 
 

 
 

 
 

Current liabilities:
 

 
 

 
 

 
 

 
 

Current portion of long-term debt
$

 
$
7,000

 
$
5,521

 
$

 
$
12,521

Accounts payable
26

 
29,555

 
32,551

 

 
62,132

Intercompany payable
246,916

 
596,366

 
93,338

 
(936,620
)
 

Accrued expenses
15,103

 
16,348

 
27,160

 

 
58,611

Income taxes payable and deferred income taxes

 
2,934

 
403

 
(2,941
)
 
396

Total current liabilities
262,045

 
652,203

 
158,973

 
(939,561
)
 
133,660

Long-term debt, less current portion
357,634

 
22,448

 
12,000

 

 
392,082

Other non-current obligations

 
2,894

 
47,069

 

 
49,963

Deferred income taxes

 
4,548

 
3,583

 

 
8,131

Long-term intercompany payable

 
71,982

 
59,374

 
(131,356
)
 

Stockholders’ equity
215,908

 
588,466

 
300,544

 
(889,010
)
 
215,908

Total liabilities and stockholders’ equity
$
835,587

 
$
1,342,541

 
$
581,543

 
$
(1,959,927
)
 
$
799,744

 
Condensed Consolidating Statement of Operations
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Net sales
$
85

 
$
242,498

 
$
188,122

 
$
(229,395
)
 
$
201,310

Operating costs and expenses:
 

 
 

 
 

 
 

 
 

Cost of sales
687

 
192,305

 
179,437

 
(215,587
)
 
156,842

Selling, general and administrative expenses
7,193

 
18,562

 
11,427

 
(13,808
)
 
23,374

Research and development
149

 
4,321

 
1,833

 

 
6,303

Restructuring charges

 
1,133

 
4,930

 

 
6,063

Net (gain) loss on sales and disposals of assets

 
(144
)
 
(430
)
 

 
(574
)
Total operating costs and expenses
8,029

 
216,177

 
197,197

 
(229,395
)
 
192,008

Operating income (loss)
(7,944
)
 
26,321

 
(9,075
)
 

 
9,302

Interest income

 

 
(5
)
 

 
(5
)
Interest expense
9,631

 
39

 
268

 

 
9,938

Other (income) expense, net
(7,373
)
 
5,935

 
(2,263
)
 

 
(3,701
)
Equity in earnings of subsidiaries
(13,116
)
 

 

 
13,116

 

Income (loss) from continuing operations before income taxes and equity income (loss) from NEC TOKIN
2,914

 
20,347

 
(7,075
)
 
(13,116
)
 
3,070

Income tax expense

 
57

 
1,302

 

 
1,359

Income (loss) from continuing operations before equity income from NEC TOKIN
2,914

 
20,290

 
(8,377
)
 
(13,116
)
 
1,711

Equity income (loss) from NEC TOKIN

 
1,367

 

 

 
1,367

Income (loss) from continuing operations
2,914

 
21,657

 
(8,377
)
 
(13,116
)
 
3,078

Income (loss) from discontinued operations

 
(2
)
 
(162
)
 

 
(164
)
Net income (loss)
$
2,914

 
$
21,655

 
$
(8,539
)
 
$
(13,116
)
 
$
2,914

 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Net sales
$
195

 
$
748,094

 
$
588,324

 
$
(707,129
)
 
$
629,484

Operating costs and expenses:
 

 
 

 
 

 
 

 
 

Cost of sales
1,712

 
626,305

 
540,184

 
(661,897
)
 
506,304

Selling, general and administrative expenses
31,338

 
50,785

 
36,772

 
(45,232
)
 
73,663

Research and development
355

 
12,918

 
5,957

 

 
19,230

Restructuring charges

 
1,695

 
7,885

 

 
9,580

Net gain (loss) on sales and disposals of assets
(9
)
 
86

 
(836
)
 

 
(759
)
Total operating costs and expenses
33,396

 
691,789

 
589,962

 
(707,129
)
 
608,018

Operating income (loss)
(33,201
)
 
56,305

 
(1,638
)
 

 
21,466

Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
Interest income

 

 
(11
)
 

 
(11
)
Interest expense
29,156

 
702

 
823

 

 
30,681

Non-operating (income) expense, net
(31,175
)
 
22,734

 
(6,388
)
 

 
(14,829
)
Equity in earnings of subsidiaries
(36,886
)
 

 

 
36,886

 

Income (loss) from continuing operations before income taxes and equity income (loss) from NEC TOKIN
5,704

 
32,869

 
3,938

 
(36,886
)
 
5,625

Income tax expense

 
290

 
4,934

 

 
5,224

Income (loss) from continuing operations before equity income (loss) from NEC TOKIN
5,704

 
32,579

 
(996
)
 
(36,886
)
 
401

Equity income (loss) from NEC TOKIN

 
(76
)
 

 

 
(76
)
Income (loss) from continuing operations
5,704

 
32,503

 
(996
)
 
(36,886
)
 
325

Income (loss) from discontinued operations

 
102

 
5,277

 

 
5,379

Net income (loss)
$
5,704

 
$
32,605

 
$
4,281

 
$
(36,886
)
 
$
5,704

Condensed Consolidating Statement of Operations
For the Quarter Ended December 31, 2013
(Unaudited)  
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Net sales
$
88

 
$
242,149

 
$
203,486

 
$
(238,384
)
 
$
207,339

Operating costs and expenses:
 

 
 

 
 

 
 

 
 

Cost of sales
376

 
212,086

 
181,109

 
(223,894
)
 
169,677

Selling, general and administrative expenses
10,276

 
15,195

 
11,450

 
(14,490
)
 
22,431

Research and development
31

 
4,072

 
1,924

 

 
6,027

Restructuring charges

 
254

 
1,940

 

 
2,194

Write down of long-lived assets

 

 
3,358

 

 
3,358

Net (gain) loss on sales and disposals of assets

 
45

 
(16
)
 

 
29

Total operating costs and expenses
10,683

 
231,652

 
199,765

 
(238,384
)
 
203,716

Operating income (loss)
(10,595
)
 
10,497

 
3,721

 

 
3,623

Non-operating (income) expense:
 
 
 
 
 
 
 
 
 
Interest income

 

 
(7
)
 

 
(7
)
Interest expense
9,977

 
302

 
70

 

 
10,349

Other (income) expense, net
(10,165
)
 
7,778

 
1,036

 

 
(1,351
)
Equity in earnings of subsidiaries
(4,587
)
 

 

 
4,587

 

Income (loss) from continuing operations before income taxes
(5,820
)
 
2,417

 
2,622

 
(4,587
)
 
(5,368
)
Income tax expense

 
53

 
980

 

 
1,033

Income (loss) from continuing operations before equity loss from NEC TOKIN
(5,820
)
 
2,364

 
1,642

 
(4,587
)
 
(6,401
)
Equity income (loss) from NEC TOKIN

 
1,657

 

 

 
1,657

Income (loss) from continuing operations
(5,820
)
 
4,021

 
1,642

 
(4,587
)
 
(4,744
)
Income (loss) from discontinued operations

 

 
(1,076
)
 

 
(1,076
)
Net income (loss)
$
(5,820
)
 
$
4,021

 
$
566

 
$
(4,587
)
 
$
(5,820
)
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Net sales
$
173

 
$
725,721

 
$
619,977

 
$
(728,026
)
 
$
617,845

Operating costs and expenses:
 

 
 

 
 

 
 

 
 

Cost of sales
1,093

 
662,619

 
554,805

 
(687,794
)
 
530,723

Selling, general and administrative expenses
30,830

 
43,755

 
36,473

 
(40,232
)
 
70,826

Research and development
174

 
12,138

 
5,391

 

 
17,703

Restructuring charges

 
2,634

 
5,534

 

 
8,168

Write down of long-lived assets

 

 
3,358

 

 
3,358

Net (gain) loss on sales and disposals of assets

 
63

 
8

 

 
71

Total operating costs and expenses
32,097

 
721,209

 
605,569

 
(728,026
)
 
630,849

Operating income (loss)
(31,924
)
 
4,512

 
14,408

 

 
(13,004
)
Non-operating (income) expense:
 

 
 

 
 

 
 

 
 

Interest income
(12
)
 
(3
)
 
(167
)
 

 
(182
)
Interest expense
30,171

 
780

 
(660
)
 

 
30,291

Other (income) expense, net
(30,139
)
 
28,223

 
1,866

 

 
(50
)
Equity in earnings of subsidiaries
22,111

 

 

 
(22,111
)
 

Income (loss) from continuing operations before income taxes
(54,055
)
 
(24,488
)
 
13,369

 
22,111

 
(43,063
)
Income tax expense (benefit)

 
142

 
4,151

 

 
4,293

Income (loss) from continuing operations before equity income (loss) from NEC TOKIN
(54,055
)
 
(24,630
)
 
9,218

 
22,111

 
(47,356
)
Equity income (loss) from NEC TOKIN

 
(2,963
)
 

 

 
(2,963
)
Income (loss) from continuing operations
(54,055
)
 
(27,593
)
 
9,218

 
22,111

 
(50,319
)
Income (loss) from discontinued operations

 

 
(3,737
)
 

 
(3,737
)
Net income (loss)
$
(54,055
)
 
$
(27,593
)
 
$
5,481

 
$
22,111

 
$
(54,056
)
Condensed Statement of Comprehensive Income [Table Text Block]
Comprehensive income (loss)
$
293

 
$
24,794

 
$
(12,135
)
 
$
(13,116
)
 
$
(164
)
Condensed Consolidating Statements of Comprehensive Income (Loss)
For the Quarter Ended December 31, 2013
(Unaudited)  
Comprehensive income (loss)
$
(4,122
)
 
$
4,686

 
$
3,220

 
$
(4,587
)
 
$
(803
)
Comprehensive income (loss)
$
(4,061
)
 
$
40,644

 
$
(8,320
)
 
$
(36,886
)
 
$
(8,623
)
Comprehensive income (loss)
$
(48,211
)
 
$
(30,289
)
 
$
14,971

 
$
22,111

 
$
(41,418
)
Condensed Consolidating Statement of Cash Flows  
Condensed
Consolidating Statement of Cash Flows
For the Nine Month Period Ended December 31, 2014
(Unaudited)
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Sources (uses) of cash and cash equivalents
 

 
 

 
 

 
 

 
 

Net cash provided by (used in) operating activities
$
31,316

 
$
(18,502
)
 
$
(16,084
)
 
$

 
$
(3,270
)
Investing activities:
 

 
 

 
 

 
 

 
 

Capital expenditures

 
(9,542
)
 
(7,932
)
 

 
(17,474
)
Change in restricted cash

 
11,509

 

 

 
11,509

Proceeds from sale of assets

 
2,274

 
2,266

 

 
4,540

Proceeds from sale of discontinued operations

 

 
9,564

 

 
9,564

Net cash used in investing activities

 
4,241

 
3,898

 

 
8,139

Financing activities:
 

 
 

 
 

 
 

 
 

Proceeds from revolving line credit

 
37,340

 
5,000

 

 
42,340

Payments of revolving line credit

 
(14,342
)
 

 

 
(14,342
)
Deferred acquisition payments
(10,899
)
 
(1,000
)
 

 

 
(11,899
)
Payments of long-term debt
(20,417
)
 

 
(1,316
)
 

 
(21,733
)
Proceeds from exercise of stock options
24

 

 

 

 
24

Net cash provided by (used in) financing activities
(31,292
)
 
21,998

 
3,684

 

 
(5,610
)
Net increase (decrease) in cash and cash equivalents
24

 
7,737

 
(8,502
)
 

 
(741
)
Effect of foreign currency fluctuations on cash

 
(1
)
 
(1,605
)
 

 
(1,606
)
Cash and cash equivalents at beginning of fiscal period
616

 
22,200

 
35,113

 

 
57,929

Cash and cash equivalents at end of fiscal period
$
640

 
$
29,936

 
$
25,006

 
$

 
$
55,582

Condensed Consolidating Statements of Cash Flows
For the Nine Month Period Ended December 31, 2013
(Unaudited)
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and Eliminations
 
Consolidated
Sources (uses) of cash and cash equivalents
 

 
 

 
 

 
 

 
 

Net cash provided by (used in) operating activities
$
(3,339
)
 
$
(30,386
)
 
$
7,413

 
$

 
$
(26,312
)
Investing activities:
 

 
 

 
 

 
 

 
 

Capital expenditures

 
(10,955
)
 
(14,038
)
 

 
(24,993
)
Change in restricted cash

 
3,532

 


 

 
3,532

Net cash used in investing activities

 
(7,423
)
 
(14,038
)
 

 
(21,461
)
Financing activities:
 

 
 

 
 

 
 

 
 

Proceeds from revolving line credit

 
9,000

 
12,000

 

 
21,000

Deferred acquisition payments
(10,703
)
 
(1,000
)
 

 

 
(11,703
)
Payments of long-term debt
(2,841
)
 
(17
)
 

 

 
(2,858
)
Proceeds from exercise of stock options
86

 

 

 

 
86

Net cash provided by (used in) financing activities
(13,458
)
 
7,983

 
12,000

 

 
6,525

Net increase (decrease) in cash and cash equivalents
(16,797
)
 
(29,826
)
 
5,375

 

 
(41,248
)
Effect of foreign currency fluctuations on cash

 
(672
)
 
1,536

 

 
864

Cash and cash equivalents at beginning of fiscal period
17,202

 
52,056

 
26,720

 

 
95,978

Cash and cash equivalents at end of fiscal period
$
405

 
$
21,558

 
$
33,631

 
$

 
$
55,594